NEURODEGENERATION

Clinical trials for NEURODEGENERATION explained in plain language.

Never miss a new study

Get alerted when new NEURODEGENERATION trials appear

Sign up with your email to follow new studies for NEURODEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Could an Immune-Modulating drug slow early Alzheimer's?

Disease control Completed

This phase 2 trial investigates whether lenalidomide, a drug that calms inflammation, can slow cognitive decline in people with mild cognitive impairment due to Alzheimer's disease. Participants take lenalidomide or a placebo for up to 12 months, followed by a 6-month washout per…

Matched conditions: NEURODEGENERATION

Phase: PHASE2 • Sponsor: St. Joseph's Hospital and Medical Center, Phoenix • Aim: Disease control

Last updated Jun 27, 2026 13:08 UTC

NEURODEGENERATION

Get alerted when new NEURODEGENERATION trials appear

Could an Immune-Modulating drug slow early Alzheimer's?